During the past decade, National Hospital Organization Chiba-East Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Chiba-East Hospital" #1 sponsor was "Pfizer" with 7 trials, followed by "Amgen" with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Chiba-East Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Chiba-East Hospital" are "Rheumatoid Arthritis" (4 trials), "Systemic Lupus Erythematosus" (4 trials), "Alzheimer Disease" (3 trials), "ALS" (1 trials) and "Active Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "National Hospital Organization Chiba-East Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Chiba-East Hospital" are "Drug" (20 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Lanabecestat" (2 trials), "MT-1186" (2 trials), "bapineuzumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Chiba-East Hospital" are 22 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Chiba-East Hospital". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in National Hospital Organization Chiba-East Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Chiba-East Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".